BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the launch of its next generation wireless rapid diagnostic system for detection of influenza A and B, ...

FRANKLIN LAKES, N.J., July 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug ...

December 19, 2011 — A new rapid test for diagnosing influenza types A and B — the first to offer a digital readout of results — has been granted a Clinical Laboratory Improvement Amendments (CLIA) ...

FRANKLIN LAKES, NJ and INDIANAPOLIS (Feb. 25, 2022) — USA Track & Field and BD, a leading global medical technology company, today announced the extension of BD’s sponsorship through 2022. As the ...

PCR tests have been hailed as the gold-standard in detecting and isolating COVID-19 cases. But they are more expensive than antigen tests and need a laboratory to process. This means it can take hours ...

New CLIA-Waived Test Delivers Digital Results to Support Timely Clinical Decision-Making FRANKLIN LAKES, N.J., July 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global ...